Evaluation of Coxiella burnetii antibiotic susceptibilities by real-time PCR assay

Journal of Clinical Microbiology

Volumn 41, Issue 5, 2003, Pages 1869-1874

  Brennan, Robert E ^a   Samuel, James E ^a  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; CHLORAMPHENICOL; CIPROFLOXACIN; RIFAMPICIN; TETRACYCLINE;

ANIMAL CELL; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL REPRODUCTION; CALCULATION; CELL LINE; CONTROLLED STUDY; COXIELLA BURNETII; DILUTION; IMMUNOFLUORESCENCE TEST; MACROPHAGE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ASSAY; RELIABILITY;

AMPICILLIN; ANIMALS; BASE SEQUENCE; CELL LINE; CHLORAMPHENICOL; CIPROFLOXACIN; COXIELLA BURNETII; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; MICE; MICROBIAL SENSITIVITY TESTS; POLYMERASE CHAIN REACTION; Q FEVER; RIFAMPIN; TETRACYCLINE;

ANIMALIA; BACTERIA (MICROORGANISMS); COXIELLA BURNETII; MURINAE;

EID: 0038629141     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.41.5.1869-1874.2003     Document Type: Article

References (27)

1. Acar, J., E. Bergogne-Berezin, Y. Chabbert, R. Cluzel, A. Courtieu, P. Courvalin, H. Dabernat, H. Drugeon, J. Duval, J. P. Flandrois, J. Fleurette, F. Goldstein, M. Meyran, C. Morel, A. Philippon, J. Sirot, C. J. Soussy, A. Thabaut, and M. Verus. 1990. Communique du comitte de l'antibiogramme. Pathol. Biol. 38:749-752.
2. Brouqui, P., H. T. Dupont, M. Drancourt, Y. Berland, J. Etienne, C. Leport, F. Goldstein, P. Massip, M. Micoud, A. Bertrand, et al. 1993. Chronic Q fever: ninety-two cases from France, including 27 cases without endocarditis. Arch. Intern. Med. 153:642-648.
3. Dellacasagrande, J., C. Capo, D. Raoult, and J.-L. Mege. 1999. IFN-γmediated control of Coxiella burnetii survival in monocytes: the role of cell apoptosis and TNF. J. Immunol. 176:2259-2265.
4. Fink, L., W. Seeger, L. Ermert, J. Hanze, U. Stahl, F. Grimminger, W. Kummer, and R. M. Bohle. 1998. Real-time quantitative RT-PCR after laser-assisted cell picking. Nat. Med. 4:1329-1333.
5. Gikas, A., D. P. Kofteridis, A. Manios, J. Pediaditis, and Y. Tselentis. 2001. Newer macrolides as empiric treatment for acute Q fever infection. Antimicrob. Agents Chemother. 45:3644-3646.
6. Gikas, A., I. Spyridaki, A. Psaroulaki, D. Kofterithis, and Y. Tselentis. 2001. In vitro susceptibility of Coxiella burnetii to trovafloxacin in comparison with susceptibilities to pefloxacin, ciprofloxacin, ofloxacin, doxycycline, and clarithromycin. Antimicrob. Agents Chemother. 42:2747-2748.
7. Htwe, K. K., T. Yoshida, S. Hayashi, T. Miyake, K.-I. Amano, C. Morita, T. Yamaguchi, H. Fukushi, and K. Hirai. 1993. Prevalence of antibodies to Coxiella burnetii in Japan. J. Clin. Microbiol. 31:722-723.
8. Huebner, R. J., G. A. Hottle, and E. B. Robinson. 1948. Action of streptomycin in experimental infection with Q fever. Public Health Rep. 63:357-362.
9. Jackson, E. R. 1951. Comparative efficacy of several antibiotics on experimental rickettsial infections in embryonnated eggs. Antibiot. Chemother. 1:231-235.
10. Marrie, T. J., and D. Raoult. 1997. Q fever - a review and issues for the next century. Int. J. Antimicrob. Agents 8:145-161.
11. Maurin, M., A. M. Benoliel, P. Bongrand, and D. Raoult. 1992. Phagolysosomal alkalinization and the bactricidal effect of antibiotics: the Coxiella burnetii paradigm. J. Infect. Dis. 166:1097-1102.
12. Maurin, M., and D. Raoult. 1997. Bacteriostatic and bactericidal activity of levofloxacin against Rickettsia rickettsii, Rickettsia conorii, Israeli spotted fever group rickettsia' and Coxiella burnetii. J. Antimicrob. Chemother. 39: 725-730.
13. Maurin, M. R., and D. Raoult. 1999. Q fever. Clin. Microbiol. Rev. 12:518-553.
14. Ormsbee, R. A., H. Parker, and E. G. Pickens. 1955. The comparative effectiveness of aureomycin, terramycin, chloramphenicol, erythromycin, and thiocymetin in suppressing experimental rickettsial infections in chick embryos. J. Infect. Dis. 96:162-167.
15. Raoult, D., M. Drancourt, and G. Vestris. 1990. Bactericidal effect of doxycycline associated with lysosomotropic agents on Coxiella burnetii in P388D1 cells. Antimicrob. Agents Chemother. 34:1512-1514.
16. Raoult, D., and T. Marrie. 1995. Q fever. Clin. Infect. Dis. 20:489-496.
17. Raoult, D., H. Torres, and M. Drancourt. 1991. Shell-vial assay: evaluation of a new technique for determining antibiotic susceptibility, tested in 13 isolates of Coxiella burnetii. Antimicrob. Agents Chemother. 35:2070-2077.
18. Samuel, J. E., M. E. Frazier, and L. P. Mallavia. 1985. Correlation of plasmid type and disease caused by Coxiella burnetii. Infect. Immun. 49:775-779.
19. Sawyers, L. A., D. B. Fishbein, and J. E. McDade. 1987. Q fever: current concepts. Rev. Infect. Dis. 9:935-946.
20. Stewart, R. D. 1997. Ph.D. dissertation. Kansas State University, Manhattan.
21. Suhan, M. L., C. Shu-Yin, and H. A. Thompson. 1996. Transformation of Coxiella burnetii to ampicillin resistance. J. Bacteriol. 178:2701-2708.
22. Whitten, K. W., R. E. Davis, and M. L. Peck. 1996. General chemistry. Harcourt Brace College Publishing, New York, N.Y.
23. Wike, D. A., G. Tallent, M. G. Peacock, and R. A. Ormsbee. 1972. Studies of the rickettsial plaque assay technique. Infect. Immun. 5:715-722.
24. Yeaman, M. R., and O. G. Baca. 1990. Antibiotic susceptibility of Coxiella burnetii, p. 213-223. In T. J. Marrie (ed.), Q fever. The disease, vol. 1. CRC Press, Boca Raton, Fla.
25. Yeaman, M. R., M. J. Roman, and O. G. Baca. 1989. Antibiotic susceptibilities of two Coxiella burnetii isolates implicated in distinct clinical syndromes. Antimicrob. Agents Chemother. 33:1052-1057.
26. Yeaman, M. R., L. A. Mitscher, and O. G. Baca. 1987. In vitro susceptibility of Coxiella burnetii to antibiotics, including several quinolones. Antimicrob. Agents Chemother. 31:1079-1084.
27. Zhang, G. Q., H. To, T. Yamaguchi, H. Fukushi, and K. Hirai. 1997. Differentiation of Coxiella burnetii by sequence analysis of the gene (com1) encoding a 27-kDa outer membrane protein. Microbiol. Immunol. 41:871-877.